2019 Symposium

2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2014 Symposium

2013 Featured Talks

Previous Symposia

2017 Featured Talks » Introduction



Introduction


Tom Marsilje, PhD
Patient Advocate






Tom Marsilje, PhD
Patient Advocate

Dr. Tom Marsilje is a 20-year oncology drug discovery scientist including being a co-inventor of the lung cancer drug “ceritinib”. He is a co-author on 25 scientific publications and is co-inventor of 19 Issued US Patents. He is also diagnosed with “currently incurable” stage IV colon cancer. He works with many different CRC patient advocacy organizations in order to increase CRC patient empowerment and education on the CRC clinical trial landscape. Advocacy highlights include helping to create and run the COLONTOWN CLINIC CRC Clinical Trial online community recently featured on NBC Evening News with Lester Holt and MSNBC and the release of a MSS-CRC curated clinical trial finder in both web & phone app formats. As a prolific writer, he writes a personal blog on life at the intersection of being both a cancer patient and researcher with readership in 140 countries “Adventures in Living Terminally Optimistic”, a science column for Fight Colorectal Cancer "The Currently Incurable Scientist", is a regular columnist on Stage IV life and issues for the Philadelphia Inquirer.